Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Cell Therapeutics, Inc. (NASDAQ: CTIC)
OKLAHOMA CITY, OK–(Marketwire – Mar 12, 2010) – On Mar 12, 2010, a category movement authorised case was filed in the United States District Court for the Western District of Washington opposite Cell Therapeutics, Inc. (NASDAQ: CTIC). The censure alleges violations of sovereign bonds laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, together with allegations of arising a array of element misrepresentations to the marketplace that had the outcome of artificially inflating the marketplace price. The category duration is from May 5, 2009 by Feb 8, 2010.
Plaintiff seeks to redeem indemnification on interest of the Class. If you have been a part of of the Class as described above, you might move the Court no after than Tuesday, May 11, 2010, to offer as a lead plaintiff for the Class. However, in sequence to do so, you contingency encounter sure authorised mandate pursuant to the Private Securities Litigation Reform Act of 1995.
If you instruct to plead this action, experience in this or any alternative lawsuit, or have any questions or concerns per this notice, or refuge of your rights, greatfully contact:
